On September 28, 2022, Shiseido Europe S.A., a subsidiary of Shiseido Company, Limited, entered into an agreement to acquire all of the outstanding shares of Gallinée Ltd ("Gallinée"), a London-based beauty brand dedicated to caring for the skin microbiome from head to toe. The acquisition of Gallinée illustrates Shiseido's commitment to the skin beauty category, helping us achieve our mission of integrating skin beauty and inner beauty, while continuing to position ourselves to "be a global winner with our heritage." This commitment is part of our "Win 2023 and Beyond" strategy, which aims to become the leading global company in the category by 2030.
Gallinée was founded in 2014 by Marie Drago, PharmD, a world-renowned expert on the skin microbiome. The skin microbiome plays a vital role on our skin and overall health by protecting us from the outside world. The brand offers a line of science-backed beauty products featuring a patented complex of prebiotics, probiotics and postbiotics that nourish and strengthen the skin microbiome. Gallinée will be a unique addition to Shiseido's existing portfolio, given its focus on beauty and wellness, as well as its differentiated positioning in the emerging field of skin microbiome. As part of the Shiseido Group, Gallinée will be able to leverage the resources of our commercial infrastructure, R＆D's extensive capabilities, particularly our European Innovation Center, to lead the development of the skin microbiome in EMEA, and cross-functional expertise to continue to drive the growth of the brand.
Following the transaction, Marie Drago, PharmD, will join Shiseido's Emea team and continue to provide product innovation and support Gallinée as the brand's Chief Creative Officer, reporting directly to Franck Marilly, President ＆ CEO, Shiseido Emea ＆ Global Fragrance.
